Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Coherus Oncology (CHRS) Debt Ratio (2016 - 2025)

Historic Debt Ratio for Coherus Oncology (CHRS) over the last 12 years, with Q3 2025 value amounting to 0.07.

  • Coherus Oncology's Debt Ratio fell 2114.18% to 0.07 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.07, marking a year-over-year decrease of 2114.18%. This contributed to the annual value of 0.11 for FY2024, which is 7172.28% down from last year.
  • As of Q3 2025, Coherus Oncology's Debt Ratio stood at 0.07, which was down 2114.18% from 0.08 recorded in Q2 2025.
  • Coherus Oncology's Debt Ratio's 5-year high stood at 0.61 during Q1 2023, with a 5-year trough of 0.07 in Q2 2024.
  • For the 5-year period, Coherus Oncology's Debt Ratio averaged around 0.25, with its median value being 0.11 (2024).
  • Its Debt Ratio has fluctuated over the past 5 years, first skyrocketed by 35927.85% in 2022, then plummeted by 8706.38% in 2024.
  • Over the past 5 years, Coherus Oncology's Debt Ratio (Quarter) stood at 0.11 in 2021, then surged by 359.28% to 0.51 in 2022, then decreased by 22.29% to 0.4 in 2023, then crashed by 71.72% to 0.11 in 2024, then crashed by 36.22% to 0.07 in 2025.
  • Its Debt Ratio stands at 0.07 for Q3 2025, versus 0.08 for Q2 2025 and 0.17 for Q1 2025.